Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
| Original language | English |
|---|---|
| Pages (from-to) | 208-213.e3 |
| Journal | Journal of Pediatrics |
| Volume | 243 |
| DOIs | |
| State | Published - Apr 2022 |
Keywords
- mRNA COVID-19 vaccine-associated myopericarditis
- outcomes
- survey
- variability
Fingerprint
Dive into the research topics of 'mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver